Log in or Sign up for Free to view tailored content for your specialty!
Sarcoma News
Heart failure drug may be ‘cardioprotective strategy’ for high-risk patients with cancer
CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage among high-risk patients with cancer, according to preliminary results of the SARAH trial.
Racial disparities in AYA cancers highlight need for targeted interventions
Stage at diagnosis and survival among younger individuals with cancer varied considerably by race, according to a retrospective cohort study.
FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.
Log in or Sign up for Free to view tailored content for your specialty!
Patients with sarcoma, mental health disorders may have poor outcomes
Published results showed patients with a mental health diagnosis who undergo surgery for bone or soft tissue sarcoma may be at risk for longer hospital stays, readmission and surgical site infection.
‘Most important study’ in soft tissue sarcomas in decades shows benefit of immunotherapy
CHICAGO — The addition of immunotherapy to radiation therapy and surgery significantly extended DFS for certain patients with soft tissue sarcoma, according to results of a randomized phase 2 trial.
Spouses of people with cancer more likely to attempt, die of suicide
Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.
FDA approves T-cell immunotherapy for advanced synovial sarcoma
The FDA granted accelerated approval to afamitresgene autoleucel for certain adults with unresectable or metastatic synovial sarcoma.
Younger generations at increased risk for several cancer types
Incidence rates for 17 different cancer types increased for successively younger generations in the United States during the past century.
Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’
It’s only the beginning.
‘Broader and more inclusive design’ needed for novel cancer trials
Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read